There is a 15 billion dose demand for a long term memory cell response vaccine that provides lifelong protection after 3 doses.
Gene therapies will require 2 booster shots a year for life. Nobody wants this anymore.
OCGN may soon become an aquisition Target because of the merit of it's American produced and OCGN owned vaccine named COVAXIN!
精彩评论